TREATMENT OF ADVANCED SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK WITH ISOTRETINOIN - A PHASE-II RANDOMIZED TRIAL

被引：42

作者：

LIPPMAN, SM

KESSLER, JF

ALSARRAF, M

ALBERTS, DS

ITRI, LM

MATTOX, D

VONHOFF, DD

LOESCHER, L

MEYSKENS, FL

机构：

[1] UNIV ARIZONA,CTR CANC,HEMATOL SECT,TUCSON,AZ 85721

[2] UNIV ARIZONA,CTR CANC,MED ONCOL SECT,TUCSON,AZ 85721

[3] WAYNE STATE UNIV,DETROIT,MI 48202

[4] HOFFMANN LA ROCHE INC,DEPT CLIN RES,NUTLEY,NJ 07110

[5] UNIV TEXAS,DEPT SURG,SAN ANTONIO,TX 78285

[6] UNIV TEXAS,DEPT MED,SAN ANTONIO,TX 78285

来源：

INVESTIGATIONAL NEW DRUGS | 1988年 / 6卷 / 01期

关键词：

D O I：

10.1007/BF00170781

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：51 / 56

页数：6

共 35 条

[1]

ALBERTS DS, 1986, J BIOL RESP MODIF, V5, P124

[2] CHEMOTHERAPY STRATEGIES IN SQUAMOUS-CELL CARCINOMA OF THE HEAD AND NECK [J].

ALSARRAF, M .

CRC CRITICAL REVIEWS IN ONCOLOGY/HEMATOLOGY, 1984, 1 (04) :323-355

[3] VARIANT OF A431 CELLS ISOLATED BY RICIN A-CONJUGATED MONOCLONAL-ANTIBODY DIRECTED TO EGF RECEPTOR - PHOSPHORYLATION OF EGF RECEPTOR AND PHOSPHATIDYLINOSITOL [J].

BEHZADIAN, MA ;

SHIMIZU, N .

SOMATIC CELL AND MOLECULAR GENETICS, 1985, 11 (06) :579-591

[4]

BESA EC, 1987, P AN M AM SOC CLIN, V6, P150

[5]

BICHLER E, 1983, 13TH P INT C CHEM, P201

[6]

BOLLAG W, 1983, LANCET, V1, P860

[7]

Burge-Bottenbley A, 1983, Nutr Cancer, V5, P121, DOI 10.1080/01635588309513788

[8]

CORDERO AA, 1981, RETINOIDS ADV BASIC, P273

[9]

GROSE WE, 1985, CANCER TREAT REP, V69, P577

[10] 13-CIS-RETINOIC ACID IN THE TREATMENT OF ORAL LEUKOPLAKIA [J].

HONG, WK ;

ENDICOTT, J ;

ITRI, LM ;

DOOS, W ;

BATSAKIS, JG ;

BELL, R ;

FOFONOFF, S ;

BYERS, R ;

ATKINSON, EN ;

VAUGHAN, C ;

TOTH, BB ;

KRAMER, A ;

DIMERY, IW ;

SKIPPER, P ;

STRONG, S .

NEW ENGLAND JOURNAL OF MEDICINE, 1986, 315 (24) :1501-1505

← 1 2 3 4 →